Skip to main content
. 2017 Jan 12;45(1):59–74. doi: 10.1177/0300060516673707

Table 3.

Pain Satisfaction Scale at week 6 in patients with osteoarthritis of the knee who were treated with either 200 mg celecoxib once daily, 800 mg ibuprofen three times daily or placebo – pairwise comparison with placebo (MITT).

Items Celecoxib 200 mg once daily n = 148 Ibuprofen 800 mg three times daily n = 150 Placebo n = 77 Statistical significancea
Celecoxib versus ibuprofen Ibuprofen versus placebo Celecoxib versus placebo
1. Happy with the duration of pain  relief 103 (69.6) 99 (66.0) 33 (42.9) NS P = 0.003 P < 0.001
2. Relieves my pain quickly enough 95 (64.2) 89 (59.3) 31 (40.3) NS P = 0.015 P = 0.002
3. Has a positive effect on my  physical health 101 (68.2) 93 (62.0) 38 (49.4) NS NS P = 0.018
4. Helps me have a better outlook  on life 92 (62.2) 87 (58.4)b 34 (44.2) NS NS P = 0.025
5. Allows me to perform my daily  activities more easily 105 (70.9) 93 (62.0) 40 (51.9) P = 0.033 NS P = 0.011
6. Allows me to perform my leisure  activities more often 105 (70.9) 90 (60.0) 35 (45.5) P = 0.020 NS P < 0.001
7. Helps me do things independently 99 (66.9) 92 (61.7)b 37 (48.1) NS NS P = 0.010
8. Allows me to have better  relationships with others 88 (59.5) 82 (55.0)b 32 (41.6) NS NS P = 0.026
9. Improves my mood 95 (64.2) 90 (60.0) 34 (44.2) NS P = 0.036 P = 0.010
10. Allows me to concentrate better 80 (54.1) 84 (56.0) 35 (45.5) NS NS NS
11. Allows me to move around  more easily 108 (73.0) 98 (65.8)b 41 (53.2) NS NS P = 0.007

Data presented as n of patients (%).

a

Significance assessed using a general linear model with treatment and centre as fixed effects, and baseline WOMAC scores as a covariate.

b

Data available for 149 patients.

MITT, modified intent-to-treat; NS, no statistically significant between-group differences (P ≥ 0.05).